Temporal analysis of cell-type proportions revealed early reduction of Somatostatin-expressing neuronal subtypes, late decreases in supragranular intratelencephalic-projecting excitatory and Parvalbum

Cell_Biology Score: 0.500 Price: $0.50 Alzheimer's disease post_mortem_brain Status: extracted

What This Experiment Tests

Cell_Biology experiment designed to assess clinical efficacy targeting N/A in post_mortem_brain. Primary outcome: Temporal analysis of cell-type proportions revealed early reduction of Somatostatin-expressing neuro

Description

Cell type proportion analysis across disease progression pseudotime

TARGET GENE
N/A
MODEL SYSTEM
post_mortem_brain
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
N/A
SOURCE
pmid_37292694
PRIMARY OUTCOME
Temporal analysis of cell-type proportions revealed early reduction of Somatostatin-expressing neuronal subtypes, late decreases in supragranular intratelencephalic-projecting excitatory and Parvalbumin-expressing neurons, and increases in disease-associated microglial and astrocytic states.

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.500 composite

Related Hypotheses (1)

TREM2-Deficient Microglia as Drivers of Amyloid Plaque Toxicity in Alzheimer's Disease0.827

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.